Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2014. Start Trial.
Date Value
October 02, 2026 0.6264
October 01, 2026 0.5742
September 30, 2026 0.6051
September 29, 2026 0.6834
September 28, 2026 0.6003
September 25, 2026 0.5695
September 24, 2026 0.6335
September 23, 2026 0.6229
September 22, 2026 0.63
September 21, 2026 0.6189
September 18, 2026 0.5709
September 17, 2026 0.5801
September 16, 2026 0.5876
September 15, 2026 0.5695
September 14, 2026 0.6834
September 11, 2026 0.6584
September 10, 2026 0.7296
September 09, 2026 0.6538
September 08, 2026 0.6478
September 04, 2026 0.6478
September 03, 2026 0.6442
September 02, 2026 0.662
September 01, 2026 0.7036
August 31, 2026 0.7036
August 28, 2026 0.7118
Date Value
August 27, 2026 0.7118
August 26, 2026 0.699
August 25, 2026 0.7022
August 24, 2026 0.6994
August 21, 2026 0.7076
August 20, 2026 0.6495
August 19, 2026 0.8578
August 18, 2026 0.725
August 17, 2026 0.7908
August 14, 2026 0.8328
August 13, 2026 0.8293
August 12, 2026 0.8542
August 11, 2026 0.9325
August 10, 2026 0.9574
August 07, 2026 1.007
August 06, 2026 0.9553
August 05, 2026 0.9788
August 04, 2026 1.034
August 03, 2026 1.073
July 31, 2026 1.046
July 30, 2026 1.130
July 29, 2026 1.060
July 28, 2026 1.043
July 27, 2026 1.182
July 24, 2026 0.8592

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 2.628
Alnylam Pharmaceuticals, Inc. 21.70
Savara, Inc. 6.877
Vericel Corp. 5.552
Biogen, Inc. 1.723

Price to Book Value Related Metrics

Price 2.64
Earnings Yield -682.3%
Market Cap 1.128M